Cargando…
114 VLPs and particle vaccines
VLPs represent a powerful tool for vaccine development, representing the closest strategy to the native viruses for displaying and delivering conformational epitopes, with improved induction of antibodies and immune response in its whole. Moreover, the lack of genetic material makes VLPs the “safer...
Autor principal: | Buonaguro, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149636/ http://dx.doi.org/10.1097/01.qai.0000446694.46916.e0 |
Ejemplares similares
-
Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation
por: Buonaguro, Luigi, et al.
Publicado: (2008) -
Zika virus-like particles (VLPs) produced in insect cells
por: de Mello, Renata Gois, et al.
Publicado: (2023) -
Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
por: Pushko, Peter, et al.
Publicado: (2020) -
Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020) -
RNA: packaged and protected by VLPs
por: Fang, Po-Yu, et al.
Publicado: (2018)